Drug treatment of tropical parasitic infections: Recent achievements and developments

Drugs

Volumn 60, Issue 5, 2000, Pages 985-995

  Stephenson, Iain ^a   Wiselka, Martin ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; AMPHOTERICIN B; ARTEMETHER; ARTEMISININ DERIVATIVE; ARTESUNATE; ATOVAQUONE; CHLOROQUINE; CIMETIDINE; CINCHONA ALKALOID; CORTICOSTEROID; CYCLOSPORIN; DIETHYLCARBAMAZINE; DIHYDROARTEMISININ; EFLORNITHINE; FLUOXETINE; HALOFANTRINE; IVERMECTIN; MEBENDAZOLE; MEFLOQUINE; MELARSOPROL; METRIFONATE; OXAMNIQUINE; PENTAMIDINE; PRAZIQUANTEL; PREDNISOLONE; PROGUANIL; QUININE; VERAPAMIL;

AFRICAN TRYPANOSOMIASIS; ARTHRALGIA; BRAIN DISEASE; CARDIOTOXICITY; COGNITIVE DEFECT; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DISEASE TRANSMISSION; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENTIATION; FEVER; FILARIASIS; HEALTH PROGRAM; HELMINTHIASIS; HUMAN; INFECTION CONTROL; MALARIA; MORBIDITY; MULTIDRUG RESISTANCE; NAUSEA; NUTRITIONAL DEFICIENCY; ONCHOCERCIASIS; PREGNANCY; REVIEW; SCHISTOSOMIASIS; VECTOR CONTROL; VERTIGO;

EID: 0033673449     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200060050-00002     Document Type: Review

References (86)

1. Fake drugs: A scourge on the system
2. Long acting chloramphenicol versus intravenous ampicillin for treatment of bacterial meningitis
3. Treatment of human gambiense trypanosomiasis with difluoromethylornithine (eflornithine)
4. Access to essential drugs in poor countries: A lost battle?
5. Resurgent malaria at the Millennium: Control strategies
6. Malaria on the move: Human population movement and transmission
7. Not much progress in the treatment of cerebral malaria
8. Vivax malaria resistant to treatment and prophylaxis with chloroquine
9. Quinine with tetracycline for the treatment of drug resistant falciparum malaria in Thailand
10. CNS adverse effects associated with antimalarials: Fact or fiction?
11. High dose mefloquine in the treatment of multidrug resistant falciparum malaria
12. Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria
13. Treatment of multidrug resistant Plasmodium falciparum malaria with three day artesunate-mefloquine combination
14. Cardiac effects of antimalarial treatment with halofantrine
15. Atovaquone and proguanil for the treatment of malaria in Brazil
16. Qinghaosu
17. Antimalarial drugs reduce cytoadherence and rosetting of Plasmodium falciparum malaria
18. A trial of artemether or quinine in Vietnamese adults with severe falciparum malaria
19. A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria
20. Neurotoxicity in animals due to arteether and artemether
21. Ataxia and slurred speech after Artesunate treatment for falciparum malaria
22. Drug resistance in malaria
23. Current concepts: The treatment of malaria
24. How much human helminthiasis is there in the world?
25. Trichuris infection and mental development in children
26. Does helminth infection affect mental processing and educational achievement
27. Weight gain of Kenyan children infected with hookworm, Trichuris trichiura and Ascaris lumbricoides is improved following once- or twice-yearly treatment with albendazole
28. Physical fitness, growth and appetite of Kenyan schoolboys with hookworm, Trichuris trichiura and Ascaris lumbricoides infections are improved four months after a single dose of albendazole
29. Effects of treatment for intestinal helminth infection on growth and cognitive performance in children: Systematic review of randomised trials
30. Mass therapy is cost effective for controlling intestinal nematodes
31. Antihelmintics: A comparative review of their clinical pharmacology
32. Effect of mebendazole therapy during pregnancy on birth outcome
33. Cimetidine increases the serum mebendazole concentrations: Implications for treatment of hepatic hydatid cysts
34. Initial observation on albendazole in combination with cimetidine for the treatment of human cystic echinococcosis
35. Double-blind placebo controlled study of concurrent administration of albendazole and praziquantel in schoolchildren with schistosomiasis and geohelminths
36. Actions of the antihelmintic ivermectin on the pharyngeal muscle of the parasitic nematode. Ascaris suum
37. Comparison of ivermectin and Diethylcarbamazine in the treatment of onchocerciasis
38. Double-blind study of ivermectin and diethylcarbamazine in African onchocercasis patients with ocular involvement
39. Ivermectin treatment of onchocercal skin lesions: Observations from placebo-controlled double-blind trial in Malawi
40. The chemotherapy of onchocercasis: Studies with ivermectin in onchocerciasis patient in northern Ghana, a region with long acting vector control
41. Adverse effects to ivermectin treatment for onchocerciasis: Results of a placebo-controlled double-blind trial in Malawi
42. Successful control of onchocerciasis with community based ivermectin distribution in the Rio Santiago focus in Ecuador
43. A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil transmitted helminths in children
44. Assessment of efficacy of diethylcarbamazine on adult Wuchereria bancrofti in vivo
45. A placebo-controlled double-blind trial for the treatment of bancroftian filariasis with ivermectin or diethylcarbamazine
46. Treatment of bancroftian filariasis in Recife, Brazil: A two year comparative study of the efficacy of single treatment with ivermectin and diethylcarbamazine
47. A controlled trial of ivermectin and diethylcarbamazine in lymphatic filariasis
48. Clearance of Wuchereria bancrofti antigen after treatment with diethylcarbamazine or ivermectin
49. Comparative efficacy of three different diethylcarbamazine regimes in lymphatic filariasis
50. Comparative trial of clearing dose and single high dose ivermectin and diethylcarbamazine against Wuchereria bancrofti microfilaraemia
51. Prolonged clearance of microfilaraemia inpatients with bancroftian filariasis after multiple high doses of ivermectin of diethlycarbamazine
52. Comparison of high dose ivermectin and diethylcarbamazine for activity against bancroftian filariasis in Haiti
53. Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitiian children
54. Efficacy of single dose combinations of albendazole ivermectin and diethylcarbamazine for the treatment of bancrofti filariasis
55. Antischistosomal drugs: Past, present and future
56. A case of refractory schistosomiasis
57. Persistence of Schistomosoma haematobium infection despite multiple courses of therapy with praziquantel
58. Drug resistant schistosomiasis: Resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific
59. Efficacy of praziquantel against Schistosoma mansoni in northern Senegal
60. Oxamniquine cures Schistosoma mansoni infection in a focus in which cure rates with praziquantel are unusually low
61. Therapeutic evaluation of two different dose regimes of praziquantel in a recent Schistosoma mansoni focus in northern Senegal
62. Chemotherapy of schistosomiasis: An update
63. The development of resistance to antihelmintics: A perspective with an emphasis on the antischistosomal drug praziquantel
64. Characterisation of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel
65. Studies on efficacy on praziquantel and mebendazole medicated salt in treatment of Echinochasmus fujianensis infection
66. Studies on taeniasis in Taiwan: Field trial on evaluation of therapeutic efficacy of mebendazole and praziquantel
67. Studies on paragonimiasis: Treatment with mebendazole, emetine and praziquantel
68. Protection against schistosomiasis produced by cyclosporin A
69. In the heart of darkness: Sleeping sickness in Zaire
70. Human African trypanosomiasis in south eastern Uganda: Clinical diversity and isoenzyme profiles
71. Human African trypanosomiasis: An emerging public health crisis
72. Gambiense trypanosomiasis: Frequency of and risk factors for failure of melarsoprol therapy
73. Risk factors for encephalopathy and mortality during melarsoprol treatment of Trypanosoma brucei gambiense sleeping sickness
74. Trial of prednisolone for prevention of melarsoprol-induced encephalopathy in gambiense sleeping sickness
75. The efficacy of pentamidine in the treatment of early-late stage Trypanosoma brucei gambiense sleeping sickness
76. A seven day course of eflornithine for relapsing Trypanosoma brucei gambiense sleeping sickness
77. Difluoromethylornithine an effective treatment of Gambian trypanosomiasis
78. Efficacy and toxicity of eflornithine for treatment of Trypanosoma brucei gambiense sleeping sickness
79. Eflornithine concentrations in serum and cerebrospinal fluid of 63 patients treated for Trypanosoma brucei gambiense sleeping sickness
80. Better health, nutrition, and education for the school aged child
81. Control of Schistosomiasis: A global picture
82. WHO celebrates triumph over river blindness